Citadel Advisors LLC trimmed its position in Safeguard Scientifics, Inc (NYSE:SFE) by 56.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 24,194 shares of the asset manager’s stock after selling 31,383 shares during the quarter. Citadel Advisors LLC’s holdings in Safeguard Scientifics were worth $271,000 at the end of the most recent quarter.
A number of other institutional investors have also recently added to or reduced their stakes in SFE. Neuberger Berman Group LLC purchased a new stake in Safeguard Scientifics in the 3rd quarter worth approximately $136,000. Nationwide Fund Advisors increased its holdings in Safeguard Scientifics by 7.6% in the 2nd quarter. Nationwide Fund Advisors now owns 14,195 shares of the asset manager’s stock worth $169,000 after acquiring an additional 1,006 shares in the last quarter. Alliancebernstein L.P. increased its holdings in Safeguard Scientifics by 27.4% in the 2nd quarter. Alliancebernstein L.P. now owns 14,430 shares of the asset manager’s stock worth $172,000 after acquiring an additional 3,100 shares in the last quarter. Voya Investment Management LLC increased its holdings in Safeguard Scientifics by 12.8% in the 2nd quarter. Voya Investment Management LLC now owns 16,710 shares of the asset manager’s stock worth $199,000 after acquiring an additional 1,896 shares in the last quarter. Finally, Parametric Portfolio Associates LLC increased its holdings in Safeguard Scientifics by 3.1% in the 2nd quarter. Parametric Portfolio Associates LLC now owns 17,132 shares of the asset manager’s stock worth $204,000 after acquiring an additional 513 shares in the last quarter. 76.54% of the stock is owned by institutional investors.
Shares of Safeguard Scientifics, Inc (NYSE:SFE) opened at $12.70 on Thursday. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.55. Safeguard Scientifics, Inc has a fifty-two week low of $10.65 and a fifty-two week high of $14.40. The stock has a market cap of $259.24, a P/E ratio of -2.93 and a beta of 1.31.
Several equities research analysts recently issued reports on the stock. Barrington Research reissued a “buy” rating and issued a $20.00 target price on shares of Safeguard Scientifics in a report on Tuesday, March 6th. Zacks Investment Research raised shares of Safeguard Scientifics from a “hold” rating to a “buy” rating and set a $14.00 target price for the company in a report on Wednesday, January 24th. Finally, Keefe, Bruyette & Woods reissued a “hold” rating and issued a $14.50 target price on shares of Safeguard Scientifics in a report on Thursday, March 1st. One investment analyst has rated the stock with a sell rating, three have given a hold rating and one has assigned a buy rating to the stock. The stock currently has an average rating of “Hold” and a consensus target price of $15.83.
TRADEMARK VIOLATION NOTICE: This piece of content was published by StockNewsTimes and is owned by of StockNewsTimes. If you are viewing this piece of content on another site, it was stolen and republished in violation of U.S. and international copyright legislation. The legal version of this piece of content can be viewed at https://stocknewstimes.com/2018/03/15/citadel-advisors-llc-has-271000-position-in-safeguard-scientifics-inc-sfe.html.
About Safeguard Scientifics
Safeguard Scientifics, Inc is engaged in providing capital to technology companies within the fields of healthcare, financial services and digital media. The Company holds interest in companies, which it refers to as partner companies. As of December 31, 2016, the Company held interests in 29 non-consolidated partner companies.
Want to see what other hedge funds are holding SFE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Safeguard Scientifics, Inc (NYSE:SFE).
Receive News & Ratings for Safeguard Scientifics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Safeguard Scientifics and related companies with MarketBeat.com's FREE daily email newsletter.